<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04987424</url>
  </required_header>
  <id_info>
    <org_study_id>CER2021</org_study_id>
    <nct_id>NCT04987424</nct_id>
  </id_info>
  <brief_title>Prevalence of Lymphedema in Valle Del Cauca, Colombia.</brief_title>
  <official_title>Prevalence Of Upper Limb Lymphedema In Patients Diagnosed With Breast Cancer In A Valle Del Cauca Oncology Institution In A 2008-2020 Cohort In Colombia.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Grupo de investigación C.E.R</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hematooncologos S.A.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Grupo de investigación C.E.R</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an epidemiological cross-sectional study aiming to determine the prevalence of&#xD;
      lymphedema and the incidence of risk factors in patients diagnosed with unilateral breast&#xD;
      cancer in a cohort from 2008 to 2020 in a specialised oncology centre in Valle del Cauca,&#xD;
      Colombia.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      CONTEXT: Breast cancer-associated lymphedema is considered one of the most frequent side&#xD;
      effects of breast cancer therapy. (1,2) Despite the abundant information available worldwide&#xD;
      on epidemiology and risk factors, little is known about these data in Colombia and Latin&#xD;
      America.&#xD;
&#xD;
      OBJECTIVE: To determine the actual prevalence and incidence of risk factors for the&#xD;
      development of lymphedema associated with breast cancer in a specialised oncology centre in&#xD;
      Valle del Cauca, Colombia.&#xD;
&#xD;
      DESIGN, SETTING, AND PATIENTS: Between 2008 and 2020 a sample of 367 patients with a&#xD;
      diagnosis of unilateral breast cancer was established, with which a descriptive study was&#xD;
      carried out, in which a series of anthropometric measurements were taken of the upper limbs&#xD;
      in order to obtain the volume of both arms and determine the prevalence of lymphedema using&#xD;
      the formula of truncated volumes of the Spanish society of lymphology, after which the&#xD;
      medical records were reviewed in order to collect other data of interest. Patients were&#xD;
      excluded if they had bilateral breast cancer or direct trauma to the upper limb.&#xD;
&#xD;
      INTERVENTIONS: A single intervention was carried out in which the patients were summoned for&#xD;
      an interview and anthropometric measurements of the upper limbs, thus calculating the arm&#xD;
      volume for a lymphedema primary diagnosis .&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">January 18, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Actual">December 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Prevalence of lymphedema</measure>
    <time_frame>2014-2020</time_frame>
    <description>Determining the prevalence of lymphedema in patients diagnosed with unilateral breast cancer</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Risk Factors</measure>
    <time_frame>2014-2020</time_frame>
    <description>Determining risk factors for the development of lymphedema in patients diagnosed with unilateral breast cancer</description>
  </secondary_outcome>
  <enrollment type="Actual">367</enrollment>
  <condition>Unilateral Breast Cancer</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Development and validation of Lymphedema levels diagnostic</intervention_name>
    <description>A single intervention was carried out in which the patients were summoned for an interview and anthropometric measurements of the upper limbs, thus calculating the arm volume for a lymphedema primary diagnosis .</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Between 2008 and 2020 a sample of 367 patients with a diagnosis of unilateral breast cancer&#xD;
        was established&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Unilateral breast cancer, cancer diagnosis between 2008-2020 in the oncology&#xD;
             institution Colombia&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Moving to a different institution for attention (other than Hemato-Oncólogos SA),&#xD;
             unwillingness to become volunteer and death, bilateral breast cancer, congenital&#xD;
             disease or trauma in the upper limb.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>98 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hematoncologos S.A</name>
      <address>
        <city>Cali</city>
        <state>Valle Del Cauca</state>
        <zip>760042</zip>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Colombia</country>
  </location_countries>
  <link>
    <url>https://www.sermef.es/wp-content/uploads/2019/01/CalculadoraLinfedema.xls</url>
    <description>Calculator of lymphology spain society to determinate the anthropometric measurements of the upper limbs, thus calculating the arm volume for a lymphedema primary diagnosis .</description>
  </link>
  <link>
    <url>https://hematooncologos.com/</url>
    <description>Hematooncologos web page</description>
  </link>
  <reference>
    <citation>Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015 Mar 1;136(5):E359-86. doi: 10.1002/ijc.29210. Epub 2014 Oct 9.</citation>
    <PMID>25220842</PMID>
  </reference>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>July 23, 2021</study_first_submitted>
  <study_first_submitted_qc>July 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 3, 2021</study_first_posted>
  <last_update_submitted>August 3, 2021</last_update_submitted>
  <last_update_submitted_qc>August 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Grupo de investigación C.E.R</investigator_affiliation>
    <investigator_full_name>Maria Isabel Cadena</investigator_full_name>
    <investigator_title>Cirujana Plástica Estética, Reconstructiva y Microcirugía</investigator_title>
  </responsible_party>
  <keyword>Lymphedema</keyword>
  <keyword>breast cancer</keyword>
  <keyword>prevalence</keyword>
  <keyword>risk factors</keyword>
  <keyword>epidemiology</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
    <mesh_term>Unilateral Breast Neoplasms</mesh_term>
    <mesh_term>Lymphedema</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

